Table 2.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
|
|
|||||
Prognostic parameter | HR | 95% CI | P value | HR | 95% CI | P value |
ACP5 expression (low vs. high) | 2.258 | 1.353-3.769 | 0.002 | 2.497 | 1.485-4.197 | 0.001 |
Age (≤ 65 vs. > 65) | 1.243 | 0.761-2.031 | 0.384 | - | - | - |
Gender (male vs. female) | 0.689 | 0.410-1.159 | 0.160 | - | - | - |
Tumor Size (≤ 5 cm vs. > 5 cm) | 1.808 | 1.097-2.979 | 0.002 | 1.710 | 1.034-2.829 | 0.037 |
CEA level (≤ 5 ng/ml vs. > 5 ng/ml) | 1.641 | 1.007-2.674 | 0.047 | 1.177 | 0.715-1.938 | 0.521 |
TNM stage (I vs. II vs. III vs. IV stage) | 2.150 | 1.530-3.023 | 0.000 | 2.278 | 1.586-3.273 | 0.000 |
HR: Hazard ratio; CI: Confidence interval. The bold number represents the P-values with significant differences.